Novo Nordisk A/SNVONYSE
Loading
Debt to Assets Over TimeElevated
Percentile Rank100
3Y CAGR+31.2%
5Y CAGR+27.5%
Studio
Year-over-Year Change

Debt-to-assets ratio

3Y CAGR
+31.2%/yr
vs +119.0%/yr prior
5Y CAGR
+27.5%/yr
Recent acceleration
Acceleration
-87.8pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.4x
Strong expansion
Streak
2 yr
Consecutive growthElevated
PeriodValueYoY Change
20250.24+9.3%
20240.22+157.0%
20230.09-19.6%
20220.11-22.0%
20210.14+91.7%
20200.07+100.2%
20190.04+667.6%
20180.00-71.9%
20170.02+604.9%
20160.00-